Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04107727. IPD Sharing: NO. Countries: 1. Publications: 1.
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
ClinicalTrials.gov study NCT03989713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ClinicalTrials.gov study NCT04293562. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
ClinicalTrials.gov study NCT03286530. IPD Sharing: NO. Countries: 1. Publications: 1.
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible
ClinicalTrials.gov study NCT01361334. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML
ClinicalTrials.gov study NCT03654703. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for
ClinicalTrials.gov study NCT03298516. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT05984199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
ClinicalTrials.gov study NCT03113643. IPD Sharing: NO. Countries: 1. Publications: 2.
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
ClinicalTrials.gov study NCT01556477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01397799. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT01063660. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
ClinicalTrials.gov study NCT04229979. IPD Sharing: NO. Countries: 10. Publications: 1.
Psychological Intervention Mobile App for Patients With AML
ClinicalTrials.gov study NCT03372291. IPD Sharing: NO. Countries: 1. Publications: 2.
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
ClinicalTrials.gov study NCT05175508. IPD Sharing: NO. Countries: 1. Publications: 11.
Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult
ClinicalTrials.gov study NCT06285136. IPD Sharing: NO. Countries: 1. Publications: 5.
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
ClinicalTrials.gov study NCT04788420. IPD Sharing: Not stated. Countries: 1. Publications: 4.
DC Vaccination for Postremission Therapy in AML
ClinicalTrials.gov study NCT01734304. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML
ClinicalTrials.gov study NCT06014489. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
ClinicalTrials.gov study NCT02073838. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.